Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “New York”
- Pulmonary Vascular Disease Phenomics Program PVDOMICSActive Not Recruiting
Sponsor: The Cleveland Clinic
Pulmonary Arterial Hypertension
United States
Sponsor: National Cancer Institute (NCI)
Endometrial Adenocarcinoma · Endometrial Adenosquamous Carcinoma · Endometrial Clear Cell Adenocarcinoma · Endometrial Serous Adenocarcinoma
United States
- A Safety Study of SEA-CD70 in Patients With Myeloid MalignanciesActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Myelodysplastic Syndrome · Acute Myeloid Leukemia
United States, Japan, Netherlands
Sponsor: Takeda
Multiple Myeloma · Secondary Immunodeficiency
United States, Australia, Austria, Brazil, Canada +11 more
Sponsor: Neurim Pharmaceuticals Ltd.
Alzheimer's Disease
United States, Canada
- A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderRecruiting
Sponsor: Pfizer
Clostridoides Difficile Associated Disease
United States, Argentina, Japan, United Kingdom
Sponsor: New York University
Childhood Apraxia of Speech
United States
- Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional HypoxemiaEnrolling By Invitation
Sponsor: State University of New York at Buffalo
Interstitial Lung Disease · Chronic Obstructive Pulmonary Disease · Hypoxemia
United States
Sponsor: Takeda
Von Willebrand Disease (VWD)
United States, France, Ireland, Italy, Japan +1 more
Sponsor: Gilead Sciences
Triple Negative Breast Cancer
United States, Australia, Belgium, Brazil, France +6 more
Sponsor: Novartis Pharmaceuticals
Geographic Atrophy Secondary to Age-related Macular Degeneration
United States, Australia, Bulgaria, Canada, Colombia +11 more
Sponsor: Novartis Pharmaceuticals
Juvenile Psoriatic Arthritis
United States
Sponsor: NewAmsterdam Pharma
Lipidemia · Type 2 Diabetes (T2DM) · Metabolic Syndrome (MetS)
United States, Czechia, Netherlands, Slovakia
Sponsor: National Cancer Institute (NCI)
Renal Pelvis and Ureter Urothelial Carcinoma
United States
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackActive Not Recruiting
Sponsor: Novo Nordisk A/S
Cardiovascular Risk · Acute Myocardial Infarction (AMI)
United States, Argentina, Australia, Brazil, Bulgaria +19 more
Sponsor: BrioHealth Solutions, Inc.
Cardiovascular Diseases · Heart Diseases · Heart Failure
United States
Sponsor: Johns Hopkins University
HIV
United States
- Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Recurrent Lung Non-Small Cell Carcinoma · Stage IV Lung Non-Small Cell Cancer AJCC v7
United States
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-essential Thrombocythemia Myelofibrosis (PET-MF)
United States, Argentina, Australia, China, India +7 more
Sponsor: Amicus Therapeutics
Fabry Disease
United States
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +25 more
Sponsor: Genmab
Advanced Solid Tumors
United States, Spain
Sponsor: Merck Sharp & Dohme LLC
Crohn Disease · Colitis, Ulcerative
United States, Czechia, France, Georgia, Hungary +2 more
- Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRDRecruiting
Sponsor: United Therapeutics
ESRD (End-Stage Renal Disease) · Kidney Transplantation · Xenotransplantation
United States